What is the role of C peptide in managing uncontrolled type 2 diabetes? —Ndukwe H. Odeluga, MD, Bakersfield, Calif. Cleaved from proinsulin to make mature insulin, C peptide can be considered a marker ...

LIVERPOOL — C-peptide testing a few years after a diagnosis of type 1 diabetes should be a routine procedure as it can help pinpoint occasional patients who have been misdiagnosed and actually have ...

A single blood test measuring C-peptide at 90 minutes after a mixed-meal challenge was a sensitive and specific measure of endogenous insulin secretion among children with new-onset type 1 diabetes, ...

Tzield, a monoclonal antibody approved for stage 2 Type 1 diabetes, now seeks approval for stage 3 disease based on trial ...

We were unable to process your request. Please try again later. If you continue to have this issue please contact [email protected]. Early near normal glucose levels did not prevent loss of ...

We were unable to process your request. Please try again later. If you continue to have this issue please contact [email protected]. Young people with new type 1 diabetes had higher ...

When the core set of symptoms are the same, how can you tell diabetes type 1.5, or LADA, apart from it's famous cousins?

The new findings come from a 15-year study examining the natural course of C-peptide in children and adolescents with type 1 diabetes (T1D). A marker of pancreatic function in patients with diabetes ...

C-peptide, a 31–amino acid peptide originally regarded as an inert by‐product of insulin synthesis, is emerging as a key modulator of diabetic complications. Secreted in equimolar amounts with insulin ...

Tandem Diabetes Care Announces Publication Showing Adults With Type 2 Diabetes Benefit from Automated Insulin Delivery Regardless of C-Peptide Levels This sub-analysis is the first study to evaluate ...

Chronic hyperglycemia can lead to microvascular injuries, which subsequently cause damage to peripheral nerve fibers. Ekberg and colleagues proposed that in type 1 diabetes a deficiency of C peptide, ...

Therapeutic effects were sustained off treatment, with persistent reduction in HbA1c and improvement in beta-cell function 3 months after last dose, suggesting disease-modifying potential of ...